770 related articles for article (PubMed ID: 9348175)
1. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
[TBL] [Abstract][Full Text] [Related]
3. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-acting antagonists of growth hormone (GH)-releasing hormone on GH and cyclic adenosine 3',5'-monophosphate release in superfused rat pituitary cells.
Horváth JE; Zarándi M; Groot K; Schally AV
Endocrinology; 1995 Sep; 136(9):3849-55. PubMed ID: 7649091
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue.
Szalontay L; Benveniste RJ; Schally AV; Vidaurre I; Nadji M; Zarandi M; Block NL; Kovacs M
Neuroendocrinology; 2012; 96(1):81-8. PubMed ID: 22377963
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone.
Zarandi M; Horvath JE; Halmos G; Pinski J; Nagy A; Groot K; Rekasi Z; Schally AV
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12298-302. PubMed ID: 7991622
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Busto R; Halmos G
J Clin Endocrinol Metab; 2001 May; 86(5):2144-52. PubMed ID: 11344219
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone.
Pinski J; Schally AV; Groot K; Halmos G; Szepeshazi K; Zarandi M; Armatis P
J Natl Cancer Inst; 1995 Dec; 87(23):1787-94. PubMed ID: 7473836
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels.
Yamashita S; Melmed S
Endocrinology; 1986 Jan; 118(1):176-82. PubMed ID: 3079701
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
[TBL] [Abstract][Full Text] [Related]
11. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.
Szepeshazi K; Schally AV; Groot K; Armatis P; Halmos G; Herbert F; Szende B; Varga JL; Zarandi M
Br J Cancer; 2000 May; 82(10):1724-31. PubMed ID: 10817510
[TBL] [Abstract][Full Text] [Related]
12. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA
Endocrinology; 2001 Sep; 142(9):3764-73. PubMed ID: 11517152
[TBL] [Abstract][Full Text] [Related]
13. Endocrine and antineoplastic actions of growth hormone-releasing hormone antagonists.
Kovács M; Schally AV; Varga JL; Zarándi M
Curr Med Chem; 2008; 15(4):314-21. PubMed ID: 18288987
[TBL] [Abstract][Full Text] [Related]
14. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of GHRH aggravated acetaminophen-induced acute mice liver injury through GH/IGF-I axis.
Wang T; Hai J; Chen X; Peng H; Zhang H; Li L; Zhang Q
Endocr J; 2012; 59(7):579-87. PubMed ID: 22572547
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma.
Jungwirth A; Schally AV; Pinski J; Groot K; Armatis P; Halmos G
Proc Natl Acad Sci U S A; 1997 May; 94(11):5810-3. PubMed ID: 9159156
[TBL] [Abstract][Full Text] [Related]
17. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
[TBL] [Abstract][Full Text] [Related]
18. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
[TBL] [Abstract][Full Text] [Related]
19. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours.
Szepeshazi K; Schally AV; Groot K; Armatis P; Hebert F; Halmos G
Eur J Cancer; 2000 Jan; 36(1):128-36. PubMed ID: 10741306
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of antagonistic analogs of GHRH on GH3 pituitary cells overexpressing the human GHRH receptor.
Kovacs M; Schally AV; Lee EJ; Busto R; Armatis P; Groot K; Varga JL
J Endocrinol; 2002 Nov; 175(2):425-34. PubMed ID: 12429040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
